Inhibitory effects of sphingosine 1-phosphate on proliferation of PC-3 human prostate cancer cells

Zoological Studies

Volumn 44, Issue 2, 2005, Pages 219-227

  Liao, Jia Jun ^a   Huang, Yu Ting ^a   Lee, Hsinyu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cell cycle arrest; Cell death; Cytoskeleton rearrangement; Prostate cancer; S1P

Indexed keywords

EID: 29144510550     PISSN: 10215506     EISSN: 1810522X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Agus DB, C Cordon-Cardo, W Fox, M Drobnjak, A Koff, DW Golde, HI Scher. 1999. Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence. J. Natl. Cancer Inst. 91: 1869-1876.
2. An S, T Bleu, Y Zheng, EJ Goetzl. 1998a. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. Mol. Pharmacol. 54: 881-888.
3. An S, EJ Goetzl, H Lee. 1998b. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J. Cell. Biochem. Supplement 30-31: 147-157.
4. 2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro. Br. J. Cancer 88: 1470-1479.
5. Daaka Y. 2002. Mitogenic action of LPA in prostate. Biochim. Biophys. Acta 1582: 265-269.
6. Davaille J, C Gallois, A Habib, L Li, A Mallat, J Tao, T Levade, S Lotersztajn. 2000. Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway. J. Biol. Chem. 275: 34628-34633.
7. Davaille J, L Li, A Mallat, S Lotersztajn. 2002. Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J. Biol. Chem. 277: 37323-37330.
8. Djakiew D. 2000. Dysregulated expression of growth factors and their receptors in the development of prostate cancer. Prostate 42: 150-160.
9. Foster CS, DG Bostwick, H Bonkhoff, JE Damber, T van der Kwast, R Montironi, WA Sakr. 2000. Cellular and molecular pathology of prostate cancer precursors. Scand. J. Urol. Nephrol. Supplement 1: 19-43.
10. Gennero I, J Fauvel, M Nieto, C Cariven, F Gaits, F Briand-Mesange, H Chap, JP Salles. 2002. Apoptotic effect of sphingosine 1-phosphate and increased sphingosine 1-phosphate hydrolysis on mesangial cells cultured at low cell density. J. Biol. Chem. 277: 12724-12734.
11. Goetzl EJ, S An. 1998. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 12: 1589-1598.
12. Goetzl EJ, M Graeler, MC Huang, G Shankar. 2002. Lysophospholipid growth factors and their G protein-coupled receptors in immunity, coronary artery disease, and cancer. Sci. World J. 2: 324-338.
13. Graler MH, R Grosse, A Kusch, E Kremmer, T Gudermann, M Lipp. 2003. The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J. Cell. Biochem. 89: 507-519.
14. Igarashi Y, Y Yatomi, TS Kickler. 1998. Sphingosine-phosphate content in the plasma of platelet concentrates correlates with poor platelet increments after transfusion and with occurrences of transfusion reactions in patients. Am. J. Hematol. 57: 261-262.
15. Kim DS, SY Kim, B Kleuser, M Schäfer-Korting, K Kim, K Park. 2004. Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase β inactivation. Cell. Signal. 16: 89-95.
16. Kue PF, JS Taub, LB Harrington, RD Polakiewicz, A Ullrich, Y Daaka. 2002. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells. Int. J. Cancer 102: 572-579.
17. Lee H. 2004. Enhancement of human endothelial cell adhesion to type I collagen by lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P). Taiwania 49: 67-79.
18. Lee H, JJ Liao, M Graeler, MC Huang, EJ Goetzl. 2002. Lysophospholipids regulation of mononuclear phagocytes. Biochim. Biophys. Acta 1582: 175-177.
19. Lee MJ, JR Van Brooklyn, S Thangada, CH Liu, AR Hand, R Menzeleev, S Spiegel, T Hla. 1998. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279: 1552-1555.
20. 3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res. 61: 5432-5440.
21. Moolenaar WH, O Kranenburg, FR Postma, GC Zondag. 1997. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr. Opin. Cell Biol. 9: 168-173.
22. Moore AN, AW Kampfl, X Zhao, RL Hayes, PK Dash. 1999. Sphingosine-a-phosphate induces apoptosis of cultured hippocampal neurons that requires protein phosphatases and activator protein-1 complexes. Neuroscience 94: 405-15.
23. Niedernberg A, A Blaukat, T Schoneberg, E Kostenis. 2003. Regulated and constitutive activation of specific signalling pathways by the human S1P5 receptor. Br. J. Pharmacol. 138: 481-493.
24. Ogbourne SM, A Suhrbrier, B Jones, SJ Cozzi, GM Boyle, M Morris, et al. 2004. Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res. 64: 2833-2839.
25. Postma FR, K Jalink, T Hengeveld, WH Moolenaar. 1996. Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO J. 15: 2388-2392.
26. Qi C, JH Park, TC Gibbs, DW Shirley, CD Bradshaw, KM Ella, KE Meier. 1998. Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells. J. Cell. Physiol. 174: 261-272.
27. Ridley AJ, A Hall. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399.
28. Seewald S, U Schmitz, C Seul, Y Ko, A Sachinidis, H Vetter. 1999. Lysophosphatidic acid stimulates protein kinase C isoforms alpha, beta, epsilon, and zeta in a pertussis toxin sensitive pathway in vascular smooth muscle cells. Am. J. Hypertens. 12: 532-537.
29. Slack-Davis JK, JT Parsons. 2004. Emerging views of integrin signaling: implications for prostate cancer. J. Cell. Biochem. 91: 41-46.
30. Spiegel S, S Milstien. 2003a. Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways. Biochem. Soc. Trans. 31: 1216-1219.
31. Spiegel S, S Milstien. 2003b. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4: 397-407.
32. Suomalainen L, JK Hakala, V Pentikainen, M Otala, K Erkkila, MO Pentikainen, L Dunkel. 2003. Sphingosine-1-phosphate in inhibition of male germ cell apoptosis in the human testis. J. Clin. Endocrinol. Metab. 88: 5572-5579.
33. Tigyi G, DJ Fischer, A Sebok, F Marshall, DL Dyer, R Miledi. 1996. Lysophosphatidic acid-induced neurite retraction in PC12 cells: neurite-protective effects of cyclic AMP signaling. J. Neurochem. 66: 549-558.
34. Tzima E, MA Del Pozo, WB Kiosses, SA Mohamed, S Li, S Chien, MA Schwartz. 2002. Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. EMBO J. 21: 6791-6800.
35. i-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell. Biol. 142: 229-240.
36. Van Brocklyn JR, Z Tu, LC Edsall, RR Schmidt, S Spiegel. 1999. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J. Biol. Chem. 274: 4626-4632.
37. Walsh GM, G Dewson, AJ Wardlaw, F Levi-Schaffer, R Moqbel. 1998. A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. J. Immunol. Meth. 217: 153-163.
38. Xie Y, TC Gibbs, KE Meier. 2002a. Lysophosphatidic acid as an autocrine and paracrine mediator. Biochim. Biophys. Acta 1582: 270-281.
39. Xie Y, TC Gibbs, YV Mukhin, KE Meier. 2002b. Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells. J. Biol. Chem. 277: 32516-32526.
40. Xu YJ, OA Aziz, P Bhugra, AS Arneja, MR Mendis, NS Dhalla. 2003. Potential role of lysophosphatidic acid in hypertension and atherosclerosis. Can. J. Cardiol. 19: 1525-1536.